InvestorsHub Logo
Followers 32
Posts 1350
Boards Moderated 0
Alias Born 12/22/2005

Re: None

Monday, 05/20/2019 6:33:42 AM

Monday, May 20, 2019 6:33:42 AM

Post# of 222540
GNCP...Take a look back to Ron's email from just May 4, 2019...15 filings complete, stop to yield to standing by for pink-current. Now focus on his last paragraph highlighted below in red font.

Sir,
 
You may rest assured that we are working non-stop to complete all of these Filings. I will NOT BE HELD TO DATES; and NO, that does NOT mean that we will miss our guided dates either.
 
We are ensuring that they are 100% accurate and that each one fully complies with all the new OTC Market requirements. Under no circumstances will we compromise on our extensive explanations, etc. as do so many other OTC Market quoted Companies.
 
Historically our Quarterly and Annual Reports ran to circa 350 pages each; we are “cutting out” unnecessary and meaningless data but nevertheless, each of these Reports are currently running at around circa 262 pages each. And that is a total of 14 Reports.
 
It is an understatement to say that is a lot of work.
 
To summarize, we will not take short cuts, abbreviate nor lower our disclosure standards whatsoever. We decided rather (if necessary) take an extra business day or two; but be right and furnish our shareholders and investors will full and accurate disclosure in enormous depth complete with very detailed notes.
 
P.S. Truthfully, the FIRST Filing being the Year Ended September 30, 2015, serves as the “Template” for all of the subsequent Filings as it details all transactions from October 1, 2013 to April 30, 2019 (That is an awful lot of disclosure and accompanying notes for a period of nearly 6 years). The subsequent Filings will contain that same data. That puts us in 100% compliance and very much within in the spirit of the revised OTC Markets Disclosure Rules.

Yes, I obviously anticipate a lot of further Press Releases, transactions, etc. Our SOLE concern is to complete and upload all of the outstanding Quarterly and Annual Reports. We have a lot waiting our consummation and due diligence reviews.

Kind Regards,
 
Ron Lowenthal